← Back to Search

Animal-Assisted Interactions for Cancer

N/A
Waitlist Available
Led By Maryjo Gilmer, PhD
Research Sponsored by Vanderbilt-Ingram Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Confirmed diagnosis of relapsed or refractory cancer
Children 3-17 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Study Summary

This trial will see if animal-assisted interactions can help reduce stress, anxiety, and improve quality of life for kids with life-threatening conditions and their parents.

Eligible Conditions
  • Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety
Pediatric Quality of Life
Stress

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Animal-Assisted InteractionsExperimental Treatment1 Intervention
Children and their caregivers randomly assigned to the intervention group will spend approximately 15 min with a registered canine and its owner during potentially anxiety-producing visits to the hospital.
Group II: Usual CareActive Control1 Intervention
Children and their caregivers randomly assigned to the usual care group will receive usual care which may include play therapy, music therapy or visits with a social worker during their visits to the hospital.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Animal-Assisted Interactions
2019
N/A
~70

Find a Location

Who is running the clinical trial?

Human Animal Bond Research InstituteUNKNOWN
Vanderbilt-Ingram Cancer CenterLead Sponsor
213 Previous Clinical Trials
60,863 Total Patients Enrolled
Maryjo Gilmer, PhDPrincipal Investigator - Vanderbilt Medical Center
Vanderbilt-Ingram Cancer Center
1 Previous Clinical Trials
71 Total Patients Enrolled

Frequently Asked Questions

~12 spots leftby Apr 2025